PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2009
CASE
AUTH/2279/11/09 Gamble ⭐ Case of the Week

AUTH/2279/11/09: Voluntary admission by Procter & Gamble

PMCPA case summary: Procter & Gamble made a voluntary admission. The published case text provided here contains no details of the allegation,…

2009
CASE
AUTH/2266/9/09 Chiesi

AUTH/2266/9/09: General Practitioner v Chiesi (Fostair) β€” No breach (conduct of representative)

GP alleged undue sales pressure and misleading statements about other practices switching to Fostair and PCT support. Panel found evidence insufficient to…

2010
CASE
AUTH/2306/3/10 Pfizer

AUTH/2306/3/10: Pharmacist v Pfizer β€” discussion of generic losartan price before MA (No breach)

A pharmacist alleged a Pfizer commercial account manager discussed losartan pricing before it was licensed. Panel noted a price list included unlicensed…

2010
CASE
AUTH/2347/8/10 Bristol-Myers Squibb Pharmaceuticals

AUTH/2347/8/10: Anonymous v Bristol-Myers Squibb (Onglyza) – alleged pressure to secure prescriptions via β€œtracker” forms and GP texts (No breach)

Anonymous GP alleged BMS reps pushed GPs to prescribe Onglyza for set patient numbers and text when targets met. Panel found insufficient…

2010
CASE
AUTH/2322/5/10 AstraZeneca

AstraZeneca voluntary admission: contract rep arranged unapproved COPD patient reviews (AUTH/2322/5/10)

A contract rep arranged and mis-described a nurse-led COPD patient review service as a speaker meeting. No written agreement or records; patients…

2020
CASE
AUTH/3306/2/20 Napp Pharmaceuticals ⭐ Case of the Week

Napp: Nyxoid described as β€œa new option” on website beyond 12 months (AUTH/3306/2/20)

PMCPA ruled Napp breached Clause 7.11 after Nyxoid was described on a corporate webpage as β€œa new option” despite being generally available…

2019
CASE
AUTH/3210/6/19 GlaxoSmithKline

AUTH/3210/6/19: Patient v GlaxoSmithKline β€” peak flow diary alleged to be out of date (No breach)

A patient complained a GSK peak flow diary dated July 2016 hadn’t been certified within two years. GSK showed certification (Oct 2016)…

2019
CASE
AUTH/3161/2/19 Leo Pharma

AUTH/3161/2/19: Employee v Leo Pharma – briefing slides on call frequency breached Clause 15.9

An employee alleged multiple promotional practice issues. Most allegations were not proven, but internal briefing slides referring to 4–5 β€œcalls” without Code…

2019
CASE
AUTH/3232/7/19

AUTH/3232/7/19 & AUTH/3233/7/19: Public complaint about congress stand visibility (Jardiance/Trajenta) – No breach

A member of the public alleged a diabetes medicine congress stand was visible/readable from a public coffee area at ExCeL London. The…

2018
CASE
AUTH/3137/12/18 Gilead Sciences Europe

AUTH/3137/12/18: ViiV Healthcare v Gilead Sciences – Biktarvy stand claims and rose imagery at HIV Glasgow

Gilead’s HIV conference stand claimed Biktarvy was β€œBetter tolerated than DTG-containing regimens” and used rose/thorn imagery. PMCPA ruled the headline claim misleading/exaggerated…

2011
CASE
AUTH/2387/2/11 ALK-Abelló ⭐ Case of the Week

ALK-AbellΓ³: Jext formulary materialsβ€”misleading β€œ33% longer shelf-life” claim (AUTH/2387/2/11)

Formulary pack/template for Jext claimed β€œ33% longer shelf-life”. Panel said wording implied patients would receive a full 24 months’ shelf life, which…

2011
CASE
AUTH/2408/6/11 Abbott Laboratories

Abbott Laboratories: EULAR 2011 conference bag sponsorship ruled an unacceptable promotional aid (AUTH/2408/6/11)

Abbott’s logo appeared on EULAR 2011 congress bags distributed in London after the 2011 Code transition period. The Panel ruled the bags…

2011
CASE
AUTH/2389/2/11 Alcon Laboratories

AUTH/2389/2/11: Allergan v Alcon – Travatan β€œthornless rose” visual and lab-data tolerability claims

A Travatan β€œBAK-free” ad used a thornless rose and animal/in vitro data implying better tolerability vs BAK formulation. PMCPA found the ad…

2008
CASE
Roche Products

Anonymous v Roche: alleged conflict of interest (rep married to hepatitis C nurse specialist) – No breach

Anonymous NHS complaint alleged conflict of interest, speaker fees, bonuses and a Caribbean reward trip linked to Pegasys sales. Panel had concerns…

2011
CASE
AUTH/2412/6/11 Eli Lilly

AUTH/2412/6/11: Anonymous v Lilly β€” Byetta samples supplied to a hospital (No breach)

Anonymous hospital staff member alleged Lilly supplied large quantities of Byetta samples to drive prescribing. Panel found sampling met Code requirements and…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training